Bladder Cancer Therapeutics Market : How the Bladder Cancer Therapeutics Market will perform in Upcoming Years based on Bladder Cancer Therapeutics Market Size, Share, Supply Volume and Major Regions!
Download Free PDF Brochure Of This Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/239
There are three major types of bladder cancer and are named on the basis of type of cells become cancerous (malignant). These type are as follows –
• Transitional Cell Carcinoma: Transitional cell carcinoma is also called as urothelial carcinoma. It begins in the urothelial cells of the bladder which are located in the lining the bladder. This is the common type of bladder cancer.
• Squamous Cell Carcinoma: This type of cancer initiates in the squamous cells and it develops in the bladder, following prolonged irritation or infection
• Adenocarcinoma: This type of cancer begins in the secretory cells (glandular) that are located in the lining of bladder. This is very rare type of bladder cancer.
According to the study of American Society of Clinical Oncology (ASCO), urothelial carcinoma accounts for around 90%, squamous cell carcinoma accounts 4% and adenocarcinoma accounts 2% of all bladder cancer. The remaining 4% bladder cancer includes other rare type of bladder cancer viz. sarcoma and small cell anaplastic cancer.
There are different types of treatment followed by doctors, which are mostly dependent on the patient’s preference for treatment and also based on type, possible side effects of the treatment and stage of bladder cancer.
Increasing incidence rate, especially in developed regions fueling growth of bladder cancer therapeutics market
As per stats released by the International Agency for Research on Cancer (IARC), 59% of bladder cancer cases are observed in developed countries, with Belgium reporting the highest number of bladder cancer cases.
As per stats released by Cancer Research UK—a charity involved in cancer research and development—here were around 10,100 new cases reported in the U.K. in 2014. Bladder cancer accounts for around 3% of all new cancer cases reported in the U.K. As per a study by the American Society of Clinical Oncology (ASCO), incidence rate of the disease has decreased by around 12% in the U.K. in the recent past.
According a study by Cancer Research Institute, bladder cancer is more prevalent among men than women. Around 77,000 new cases were diagnosed in the U.S. in 2016, leading to 16,000 deaths. Continuous advancements in clinical research resulted into increased survival rate of people suffering from bladder cancer, which is around 77% observed in last few years. As per the stats of American Cancer Society, bladder cancer accounts for 5% of all new cancer cases in the U.S.
Some are the major reasons behind bladder cancer are unhealthy habits. Smoking is a major cause along with that continuous exposure of industrial chemicals, drinking water with high level of arsenic, family history of bladder cancer, and long-term use of urinary catheters are the other causes of bladder cancer. In Africa and Middle East schistosomiasis and infested water are the leading cause of bladder cancer.
For More Information About This Report @ https://www.coherentmarketinsights.com/ongoing-insight/bladder-cancer-therapeutics-market-239
North America holds major share in the global bladder cancer therapeutics market, followed by Europe due to advanced treatments, developed economy, and easy access to advanced healthcare facilities. The market in APAC region will witness high growth rate in the near future, due to increasing per capita income, developing economy, government initiatives on improving healthcare infrastructure, growing FDI in healthcare, and rapidly increasing aging population. As per stats released by the Department of Industrial Policy and Promotion (DIPP), the healthcare sector in India witness FDI worth US$ 4.09 billion between April 2000 and September 2016. Also, medical tourism in the region is a flourishing business, due to easy access to high-quality low-cost treatment option. According to data released by the India Brand Equity Foundation (IBEF)— a Trust established by the Department of Commerce, Ministry of Commerce and Industry, Government of India—the medical tourism industry in India rakes in US$ 3 billion each year. This creates a highly conducive environment for growth of the bladder cancer therapeutics market in the region.
Conversely, increasing use of generic drugs, high cost of treatment, asymptomatic nature of the disease and fewer pipeline products inhibit growth of the market. As per data released by the American Cancer Society, only one drug received approval from FDA in last three decade.
Global Key Players:
The major companies playing key role in bladder therapeutics market are Sanofi S.A., F. Hoffmann-La Roche AG, Novartis, Pfizer, Eli Lilly and Co., GlaxoSmithKline, Bristol-Myers Squibb, Allergan Inc, AVI Biopharma Inc., and AstraZeneca plc. Some are the major drugs approved by Food and Drug Administration used for the treatment of bladder cancer are Cisplatin, Nivolumab, Thiotepa, Atezolizumab, Doxorubicin Hydrochloride, Opdivo (Nivolumab), Platinol-AQ (Cisplatin), Platinol (Cisplatin), and Tecentriq (Atezolizumab).
Bladder cancer therapeutics market taxonomy:
Global Market by Bladder Cancer Type
• Urothelial Carcinoma
• Squamous Cell Carcinoma
Global Market by Treatment Type
◦ Transurethral bladder tumor resection (TURBT)
◦ Urinary Diversion
◦ Intravesical (local) Chemotherapy
◦ Systemic (whole body) Chemotherapy
◦ Intravesical Therapy
◦ Interferon Therapy
• Radiation Therapy
Global Market by Test Type
• Urine Cytology
• Bladder Ultrasound
Request For Customization @ https://www.coherentmarketinsights.com/insight/request-customization/239
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Coherent Market Insights
1001 4th Ave,
Seattle, WA 98154
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Bladder Cancer Therapeutics Market : How the Bladder Cancer Therapeutics Market will perform in Upcoming Years based on Bladder Cancer Therapeutics Market Size, Share, Supply Volume and Major Regions! here
News-ID: 1557796 • Views: 662
More Releases from Coherent Market Insights
Proteomics Market 2023 Massive Hit Industry Growth in Upcoming Year 2030 | Therm …
The proteomics market is estimated for 2023 at USD 40 billion for the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. Proteomics is the study of proteomes by examining structure and function of proteins. It involves identification and quantification of proteins produced by genomes. Proteomics tools help in understanding complex biological systems and diseases at protein level. Market Dynamics: The proteomics market is expected to witness
Hospital Capacity Management Systems Market See Booming Growth 2023-2030 with Bo …
The Hospital Capacity Management Systems Market is estimated to be valued at US$ 1,256.5 million in 2023 and is expected to exhibit a CAGR of 5.4% during the forecast period (2023-2030). Market Overview: Hospital capacity management systems help manage bed occupancy, patient admissions and transfers, waiting lists, elective lists, theater schedules and outpatient appointments in hospitals. These systems help optimize resource utilization in hospitals. Market Dynamics: The hospital capacity management systems market is
Nanoparticles Market Expected to Remain High in North America during 2023-2030 | …
Nanoparticles Market: Driving Growth and Empowering Businesses Market Trends, Opportunities, and Insights Coherent Market Insights, a prominent Market Research Firm, presents a comprehensive research report on the "Nanoparticles ". This report aims to provide valuable insights and analysis to industry professionals, investors, analysts, policymakers, and other clients. With years of experience and expertise in the industry, we are committed to delivering accurate and reliable market intelligence to empower businesses and individuals in
Nanoemulsion Market 2023-2030: Top Manufactures, Market Size, Applications and F …
Nanoemulsion Market: Driving Growth and Empowering Businesses Market Trends, Opportunities, and Insights Coherent Market Insights, a prominent Market Research Firm, presents a comprehensive research report on the "Nanoemulsion ". This report aims to provide valuable insights and analysis to industry professionals, investors, analysts, policymakers, and other clients. With years of experience and expertise in the industry, we are committed to delivering accurate and reliable market intelligence to empower businesses and individuals in
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose. Increase in incidence of target diseases like cancer is key driving factor which is expected to boost
Oncology Nutrition Market led to an unprecedented rise by 2025 : liver cancer, p …
Global Oncology Nutrition Market: Overview Cancer diagnosis creates myriad questions about diet and nutrition. Those pertain to if the food will make a patient feel sick to what should be ingested to fight cancer. This has spawned the oncology nutrition market which has been rising steadily due to the increasing cases of different types of cancer worldwide. During cancer treatment one needs to eat right in order to build up strength
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top